CMS froze DMEPOS enrollment in February. The freeze is almost over — and that's not the whole story.
A six-month moratorium on new DMEPOS supplier enrollment is nearing its planned end. What it did to prosthetic-care access, who bore the friction cost, and what to ask your payer before assuming the problem resolves itself.

On February 27, CMS imposed a moratorium on new DMEPOS supplier enrollment. The reason given: fraud and abuse within the enrollment system. The planned duration: six months. That puts the expiration window somewhere around late August — which is now.
If you have spent any part of this year trying to find an in-network prosthetist or orthotist and coming up short, the moratorium is not the only explanation, but it is one of them.
What DMEPOS is, and why enrollment matters
DMEPOS is the CMS acronym for durable medical equipment, prosthetics, orthotics, and supplies. It is the category that governs how Medicare-participating providers bill for prosthetic limbs, orthotic devices, and associated components.
To bill Medicare — and, by extension, to appear in Medicare Advantage and many commercial plans’ in-network directories — a DMEPOS supplier has to be enrolled with CMS. Enrollment involves accreditation, site inspections, surety bonds, and a queue.
When CMS imposes an enrollment moratorium, new applications stop moving forward in the affected category or geography. The logic is containment: freezing new enrollment limits how quickly fraudulent actors can obtain billing numbers. The administrative intent is coherent. The collateral effect is that legitimate new providers, newly credentialed clinicians, and expanding practices cannot get into the network until the freeze lifts.
Who absorbed the friction
Fraud in DMEPOS billing is documented and ongoing. CMS is not wrong that the enrollment pipeline has been a vector for it. But a moratorium is a category-wide pause, and the cost is not borne evenly.
A large, multi-location O&P practice navigating the moratorium has compliance staff and established revenue. A new independent clinic, a clinician who relocated to an underserved area, or a small supplier trying to establish a first location somewhere that lacks in-network coverage — each of those situations stalls entirely. They cannot see patients at Medicare rates. They cannot appear on the plan directory. They wait.
The geographic dimension is the part that does not get said often enough. In areas where the existing O&P network was already thin, a six-month freeze on expansion is not an inconvenience. It is a lid on access precisely where the access problem was already worst.
The compliance weight The O&P EDGE is tracking
The O&P EDGE reported this moratorium in the context of compliance risks for O&P providers — meaning the legal and billing exposure that builds up when enrollment status is uncertain, delayed, or contested. That framing is worth following because compliance pressure on small O&P practices has a downstream effect on the market structure: it accelerates consolidation.
Independent and community-based O&P clinics consistently cite administrative overhead — enrollment mechanics, documentation burdens, billing disputes — as a factor in whether they can sustain operations. When the overhead spikes, some practices sell to consolidators or close. The patient result is a network with fewer independent options and more travel required to reach care.
What to watch as the planned expiration approaches
A moratorium lifting does not flip a switch. The sequence, if the freeze ends on schedule, would look something like:
- Applications that were pending or planned resume processing, subject to the same accreditation and inspection queue that existed before February.
- New providers in affected areas still need weeks to months to complete enrollment before they appear in network directories and can bill.
- CMS may modify, renew, or extend the moratorium rather than letting it expire cleanly. Prior DMEPOS moratoriums have had complicated endings.
None of that suggests the access landscape improves quickly. It suggests the bottleneck shifts — from “frozen” to “processing slowly.”
What to do now, not in late August
If you are currently navigating an access gap — an out-of-network situation, a care gap because your provider recently stopped accepting your plan, or difficulty finding any enrolled prosthetist within a reasonable distance — the useful moves are:
- Call your plan’s member services and ask specifically what DMEPOS-enrolled O&P providers are currently listed in your area. Get a number, not a reassurance.
- If the list is short, ask your plan what its network adequacy obligations are in your state for this category of care. Many states have regulations that require insurers to ensure members can access in-network care within specific distance or time limits. If those limits are not being met, you may have grounds to request an out-of-network exception at in-network rates.
- Document the access situation now. If you have been paying out of pocket or going without care because of enrollment gaps, written records of that gap are useful if you need to escalate to your state insurance commissioner or file a formal network adequacy complaint.
Moratorium expiration will not automatically find you a provider. The system does not work that way, and the burden of navigating it should not fall only on patients — but practically, it often does.
Amputee News does not provide individualized insurance, legal, or benefits advice. Coverage, network adequacy, and provider enrollment vary by payer, plan, and geography. Contact your insurer, your state insurance commissioner, and your care team directly with specific questions about your situation.
Source notebook: This reporting draws on The O&P EDGE report on DMEPOS enrollment moratorium compliance risks for O&P providers ↗. We link out so you can follow the receipts.